These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The tubular excretion of benzylpenicillin in patients with cystic fibrosis. Bins JW, Mattie H. Br J Clin Pharmacol; 1989 Mar; 27(3):291-4. PubMed ID: 2719893 [Abstract] [Full Text] [Related]
5. Inhibitory effects of p-aminohippurate and probenecid on the renal clearance of adefovir and benzylpenicillin as probe drugs for organic anion transporter (OAT) 1 and OAT3 in humans. Maeda K, Tian Y, Fujita T, Ikeda Y, Kumagai Y, Kondo T, Tanabe K, Nakayama H, Horita S, Kusuhara H, Sugiyama Y. Eur J Pharm Sci; 2014 Aug 01; 59():94-103. PubMed ID: 24747579 [Abstract] [Full Text] [Related]
6. Active transport of benzylpenicillin across the blood-milk barrier. Schadewinkel-Scherkl AM, Rasmussen F, Merck CC, Nielsen P, Frey HH. Pharmacol Toxicol; 1993 Jul 01; 73(1):14-9. PubMed ID: 8234185 [Abstract] [Full Text] [Related]
13. No effect of probenecid on the renal excretion mechanism of a new carbapenem, DA-1131, in dogs. Kim SH, Kim WB, Lee MG. Res Commun Mol Pathol Pharmacol; 1998 Jul 01; 101(1):85-92. PubMed ID: 9755846 [Abstract] [Full Text] [Related]
14. Evidence for a postsecretory reabsorptive site for uric acid in man. Diamond HS, Paolino JS. J Clin Invest; 1973 Jun 01; 52(6):1491-9. PubMed ID: 4703233 [Abstract] [Full Text] [Related]